To the U.S. Department of Health and Human Services, Food and Drug Administration, and Health Resources and Services Administration: I support a carefully defined pathway to regulate isolated, otherwise unmodified pancreatic islets recovered from deceased donors for...

Today The Cure Alliance is proud to announce two new partnerships that advance both halves of our mission: curing and preventing chronic, debilitating, and fatal diseases. First, we are supporting the research of Dr. Rumela Chakrabarti as she tests new ways to stop...

From an Idea to a Registrational Pathway for Islet Transplantation This milestone represents the culmination of a remarkable scientific and translational journey that began nearly a decade ago. At NobleCon in 2018, Dr. Camillo Ricordi, as a member of Noble Capital...

Stimulated by the extremely promising preliminary results from our pilot study involving 12 patients, Eledon Pharmaceuticals has submitted an IND application to the U.S. Food and Drug Administration (FDA). This represents the first and a very important step toward...

Stunning Results of First Human Trials Presented Today in Boston at 5th Summit on Stem Cell Derived Islets MIAMI, FL, UNITED STATES, October 29, 2024 /EINPresswire.com/ — The Cure Alliance, a 501(c)(3) nonprofit, is excited to announce that three patients with type 1...

Dear Friends, In recent years, The Cure Alliance (TCA) has proudly contributed to clinical trials of stem cell infusions (MSC) in severe COVID-19, and in chronic kidney disease (CKD), providing critically important information on the safety, efficacy, and mechanism of...

Miami/September 29, 2023/A phase II clinical trial hoping to silence the deadliest form of pancreatic cancer has started enrolling patients at SUNY Downstate Medical Center in Brooklyn, N.Y., The Cure Alliance announced today. Pancreatic Ductal Adenocarcinoma Cancer...